ATS 2024 Final Program

Click on the session title to view the speakers

127

MONDAY • MAY 20

BEHAVIORAL • CLINICAL MINI SYMPOSIUM

BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

B20 LUNG SCREENING: ONE SIZE DOES NOT FIT ALL 9:15 a.m. - 11:15 a.m. San Diego Convention Center Room 30A-B (Upper Level) 9:15 Association of Electronic Cigarette Use After Conventional Smoking Cessation With Lung Cancer Risk: A Nationwide Cohort Study 9:27 The Potential for an Algorithmic Smoking History Assessment to Improve Detection of Lung Cancer Screening-Eligible Patients in an Outpatient Pulmonology Clinic 9:39 Development and Performance of Alternative Simple Lung Cancer Screening Eligibility Criteria in the US Population: Comparison to USPSTF Criteria 9:51 Assessing Lung Cancer Risk in Breast Cancer Survivors 10:03 Targeting High Risk of Lung Cancer Enriches for Comorbidities Associated With Harms From Screening in a National Lung Screening Trial Subgroup (n=18,463) 10:15 Respiratory Symptoms Present When Assessed for the Summit Study, A Lung Cancer Screening Study 10:27 Racial Disparities in Annual Lung Cancer Screening Follow-up: An Updated Analysis of a Multicenter Cohort Study 10:39 Racial Differences in Lung Cancer Risk Distribution Using the Plcom2012, PLCOm2012Norace, and PLCOmRace3l Risk Models in a USPSTF-eligible Screening Cohort Recommendations on Racial Disparities in Lung Cancer Screening Eligibility 11:03 Evaluation of Early Lung Cancer Detection in a Population at High Risk Due to Occupation: Eligibility Criteria and Impact 10:51 The Impact of the 2023 ACS Screening

B21 RESEARCH STUDIES IN

INTERVENTIONAL PULMONARY AND PLEURAL DISEASE

9:15 a.m. - 11:15 a.m.

San Diego Convention Center Room 5A-B (Upper Level)

Poster Viewing

9:15-10:00

Discussion 10:00-11:15 601 Trends in Characteristics and Outcomes of Hospital Inpatients Undergoing Bronchoscopic Lung Volume Reduction in the United States, 2016-2020 602 Characterizing Adverse Events in Using the Spiration Valve System as Reported by the Food and Drug Administration 603 A Systematic Review of Adverse Events in Patients Undergoing Endobronchial Valve Therapy for Chronic Obstructive Pulmonary Disease 604 A Retrospective Analysis of In-hospital Vs Out-of-Hospital Pneumothoraxes After BLVR in a Rural Community Setting 605 Bronchoscopic Lung Volume Reduction: Machine Learning Mathematical Model for Target Lobe Selection 606 Outcomes of Bronchoscopic Lung Volume Reduction in Patients With Static and Dynamic Hyperinflation 607 Combined Endobronchial Valve Placement and Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema: A Pilot Randomized Controlled Trial (COMPLETE-1) 608 Inter-lobar Fissure Completion as a Salvage Treatment in Patients With Failed Lung Volume Reduction (SAVED-1) 609 The Efficacy and Safety of Endobronchial Valve Placement in Patients With Chronic Obstructive Pulmonary Disease With Underlying Congestive Heart Failure: A Propensity-matched National Study

ATS 2024 Conference Program • San Diego, CA